Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2379487생성일: 2026년 10월 25일
Dicyclohexylcarbodiimide → 3-(3,5-Di-tert-butyl-4-hydroxycinnamoylamino)-4-(2-chlorophenyl)-6,8-dimethylquinoline
https://huagongshe.com/reaction/2379487
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Dicyclohexylcarbodiimide | HCID 10868 | — |
| 반응물 | 1-Hydroxybenzotriazole | HCID 75771 | — |
| 반응물 | 3-(3,5-Ditert-butyl-4-hydroxyphenyl)prop-2-enoic acid | HCID 99819 | — |
| 반응물 | 3-Amino-4-(2-chlorophenyl)-6,8-dimethylquinoline | HCID 10446536 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 3-(3,5-Di-tert-butyl-4-hydroxycinnamoylamino)-4-(2-chlorophenyl)-6,8-dimethylquinoline | HCID 53798901 | 47.5% |
반응 단계
1-Hydroxybenzotriazole (154 mg) and dicyclohexylcarbodiimide (272 mg) were added to a solution of 3,5-di-tert-butyl-4-hydroxycinnamic acid (331 mg) in DMF (5 ml). The mixture was stirred at room temperature for minutes, and then, 3-amino-4-(2-chlorophenyl)-6,8-dimethylquinoline (288 mg) was added thereto. The resultant mixture was further stirred at room temperature for 24 hours. The insoluble materials were filtered off, while the filtrate was diluted with water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and dried (MgSO4). The solvent was removed, and the residue was purified by a silica gel chromatography with benzene-acetone (9:1), then, crystallized from isopropyl ether to give 3-(3,5-di-tert-butyl-4-hydroxycinnamoylamino)-4-(2-chlorophenyl)-6,8-dimethylquinoline (257 mg, 47.5%) as colorless needles.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05362742 |
|---|
| 출처 데이터셋 | uspto-grants-1994_11 |
|---|
| ORD ID | ord-98e97a8dae82496c9ce64dca0b50cc24 |
|---|
| 출처 메모 | uspto-grants-1994_11 |
|---|